IDO1 and neoplasm: Importantly, IDO expression by tumors is inversely correlated with tumor-infiltrating TCD8 numbers in several types of malignancies including esophageal, ovarian and endometrial carcinomas, and may contribute to a poor clinical outcome [17]–[19].